These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8721271)

  • 1. The effect of age and concomitant treatment with other psychoactive drugs on serum concentrations of citalopram measured with a nonenantioselective method.
    Leinonen E; Lepola U; Koponen H; Kinnunen I
    Ther Drug Monit; 1996 Apr; 18(2):111-7. PubMed ID: 8721271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of escitalopram in an outpatient setting.
    Reis M; Chermá MD; Carlsson B; Bengtsson F;
    Ther Drug Monit; 2007 Dec; 29(6):758-66. PubMed ID: 18043473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography method for analyzing citalopram and desmethylcitalopram from human serum.
    Akerman KK; Jolkkonen J; Huttunen H; Penttilä I
    Ther Drug Monit; 1998 Feb; 20(1):25-9. PubMed ID: 9485550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites.
    Olesen OV; Linnet K
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):83-8. PubMed ID: 8634772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
    Eap CB; Bouchoux G; Amey M; Cochard N; Savary L; Baumann P
    J Chromatogr Sci; 1998 Jul; 36(7):365-71. PubMed ID: 9679303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.
    Reis M; Olsson G; Carlsson B; Lundmark J; Dahl ML; Wålinder J; Ahlner J; Bengtsson F
    J Clin Psychopharmacol; 2002 Aug; 22(4):406-13. PubMed ID: 12172341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum.
    Tournel G; Houdret N; Hédouin V; Deveau M; Gosset D; Lhermitte M
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(2):147-58. PubMed ID: 11587344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.
    Reis M; Lundmark J; Bengtsson F
    Ther Drug Monit; 2003 Apr; 25(2):183-91. PubMed ID: 12657912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.
    Reis M; Aamo T; Spigset O; Ahlner J
    Ther Drug Monit; 2009 Feb; 31(1):42-56. PubMed ID: 19077925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring citalopram in blood and cerebrospinal fluid: revealing a distribution pattern that differs from other antidepressants.
    Paulzen M; Lammertz SE; Gründer G; Veselinovic T; Hiemke C; Tauber SC
    Int Clin Psychopharmacol; 2016 May; 31(3):119-26. PubMed ID: 26650488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of citalopram and desmethylcitalopram by liquid chromatography with fluorescence detection after solid-phase extraction.
    Meng QH; Gauthier D
    Clin Biochem; 2005 Mar; 38(3):282-5. PubMed ID: 15708552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19.
    Holmgren P; Carlsson B; Zackrisson AL; Lindblom B; Dahl ML; Scordo MG; Druid H; Ahlner J
    J Anal Toxicol; 2004 Mar; 28(2):94-104. PubMed ID: 15068562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of citalopram enantiomers and metabolites in elderly patients.
    Foglia JP; Pollock BG; Kirshner MA; Rosen J; Sweet R; Mulsant B
    Psychopharmacol Bull; 1997; 33(1):109-12. PubMed ID: 9133760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.
    Brøsen K; Naranjo CA
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):275-83. PubMed ID: 11532381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.
    de Mendonça Lima CA; Baumann P; Brawand-Amey M; Brogli C; Jacquet S; Cochard N; Powell-Golay K; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):952-6. PubMed ID: 16006029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Citalopram and desmethylcitalopram for psychiatric patients].
    Linnet K; Olesen OV
    Ugeskr Laeger; 1996 Aug; 158(35):4920-3. PubMed ID: 8801700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of concomitant medications on the total clearance and the risk for supra-therapeutic plasma concentrations of Citalopram. A population-based cohort study.
    Wenzel-Seifert K; Brandl R; Hiemke C; Haen E
    Pharmacopsychiatry; 2014 Nov; 47(7):239-44. PubMed ID: 25372890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
    Sit DK; Perel JM; Helsel JC; Wisner KL
    J Clin Psychiatry; 2008 Apr; 69(4):652-8. PubMed ID: 18426260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.
    Akil A; Bies RR; Pollock BG; Avramopoulos D; Devanand DP; Mintzer JE; Porsteinsson AP; Schneider LS; Weintraub D; Yesavage J; Shade DM; Lyketsos CG
    J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):99-109. PubMed ID: 26611790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.